SCHEMBL16638735

SCHEMBL16638735

Cc1nc2c(n1C)CCCC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.36
HPGD P15428 3/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
TSHR P16473 1/20 0.34
MAPK10 P53779 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
AGTR1 P30556 1/20 0.32
AGTR2 P50052 1/20 0.32
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31
CYP1A2 P05177 1/20 0.31
POLB P06746 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23712823 0.98 KDM4E (0.35) KDM4EHPGDNPC1RAB9ATSHR
SCHEMBL23712947 0.98 KDM4E (0.35) KDM4EHPGDNPC1RAB9ATSHR
SCHEMBL10252360 0.95 KDM4E (0.36) KDM4EHPGDNPC1RAB9ATSHR
SCHEMBL10671834 0.72 AGTR1 (0.40) KDM4ETSHRALDH1A1LMNAHTT
SCHEMBL1159646 0.72 CYP2C19 (0.41) HPGDALDH1A1LMNAHTTCYP1A2
SCHEMBL24575215 0.72 KMT2A (0.33) KDM4ERAB9ATSHRMAPK10KMT2A
SCHEMBL8277482 0.72 PDCD1 (0.38) HPGDALDH1A1LMNAHTTCYP1A2
SCHEMBL17895819 0.71 KDM4E (0.44) KDM4EHPGDALDH1A1MEN1HTT
SCHEMBL9570441 0.69 KDM4E (0.31) KDM4EHPGDTSHRALDH1A1HSD17B10
SCHEMBL9570106 0.69 AGTR1 (0.35) KDM4EHTTAGTR1AGTR2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006237-B2 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases JANSSEN PHARMACEUTICA NV (BE) 2015-04-14 US disclosed